Display options
Cite
Q&A: Lisa H. Butterfield, Elizabeth M. Jaffee, and Arlene H. Sharpe on the SITC-AACR Joint Workshop, "The Cancer Biology Underlying Immunotherapy-Induced Autoimmunity". Cancer Immunol Res. 2021;9(9):997-998doi: 10.1158/2326-6066.CIR-21-0337.
(2021). Q&A: Lisa H. Butterfield, Elizabeth M. Jaffee, and Arlene H. Sharpe on the SITC-AACR Joint Workshop, "The Cancer Biology Underlying Immunotherapy-Induced Autoimmunity". Cancer immunology research, 9(9), 997-998. https://doi.org/10.1158/2326-6066.CIR-21-0337
"Q&A: Lisa H. Butterfield, Elizabeth M. Jaffee, and Arlene H. Sharpe on the SITC-AACR Joint Workshop, "The Cancer Biology Underlying Immunotherapy-Induced Autoimmunity"." Cancer immunology research vol. 9,9 (2021): 997-998. doi: https://doi.org/10.1158/2326-6066.CIR-21-0337
Q&A: Lisa H. Butterfield, Elizabeth M. Jaffee, and Arlene H. Sharpe on the SITC-AACR Joint Workshop, "The Cancer Biology Underlying Immunotherapy-Induced Autoimmunity". Cancer Immunol Res. 2021 Sep;9(9):997-998. doi: 10.1158/2326-6066.CIR-21-0337. PMID: 34470818.
Copy Download .nbib Format: NLM
Share it on

Cancer Immunol Res. 2021 Sep;9(9):997-998. doi: 10.1158/2326-6066.CIR-21-0337.

Q&A: Lisa H. Butterfield, Elizabeth M. Jaffee, and Arlene H. Sharpe on the SITC-AACR Joint Workshop, "The Cancer Biology Underlying Immunotherapy-Induced Autoimmunity".

Cancer immunology research

[No authors listed]

PMID: 34470818 DOI: 10.1158/2326-6066.CIR-21-0337

Abstract

©2021 American Association for Cancer Research.

Publication Types